Fuchs CS - Search Results

1

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors.

Strosberg JR, Chan JA, Ryan DP, Meyerhardt JA, Fuchs CS, Abrams T, Regan E, Brady R, Weber J, Campos T, Kvols LK, Kulke MH. Strosberg JR, et al. Among authors: fuchs cs. Endocr Relat Cancer. 2013 May 21;20(3):383-90. doi: 10.1530/ERC-12-0390. Print 2013 Jun. Endocr Relat Cancer. 2013. PMID: 23572164 Free PMC article. Clinical Trial.

2

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.

Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: fuchs cs. Cancer. 2000 Jan 1;88(1):180-5. doi: 10.1002/(sici)1097-0142(20000101)88:1<180::aid-cncr25>3.3.co;2-h. Cancer. 2000. PMID: 10618622 Clinical Trial.

3

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: fuchs cs. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Free article. Clinical Trial.

4

Chemotherapy options for gastric cancer.

Meyerhardt JA, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Semin Radiat Oncol. 2002 Apr;12(2):176-86. doi: 10.1053/srao.2002.30823. Semin Radiat Oncol. 2002. PMID: 11979419 Review.

5

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.

Fuchs CS, Clark JW, Ryan DP, Kulke MH, Kim H, Earle CC, Vincitore M, Mayer RJ, Stuart KE. Fuchs CS, et al. Cancer. 2002 Jun 15;94(12):3186-91. doi: 10.1002/cncr.10607. Cancer. 2002. PMID: 12115351 Free article.

6

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.

Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS. Kulke MH, et al. Among authors: fuchs cs. Cancer J. 2002 Sep-Oct;8(5):395-9. doi: 10.1097/00130404-200209000-00010. Cancer J. 2002. PMID: 12416897 Clinical Trial.

7

A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.

Michaelson MD, Ryan DP, Fuchs CS, Supko JG, Garcia-Carbonero R, Paul Eder J, Clark JW. Michaelson MD, et al. Among authors: fuchs cs. Cancer. 2003 Jan 1;97(1):148-54. doi: 10.1002/cncr.11038. Cancer. 2003. PMID: 12491516 Free article. Clinical Trial.

8

Impact of diabetes mellitus on outcomes in patients with colon cancer.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. J Clin Oncol. 2003 Feb 1;21(3):433-40. doi: 10.1200/JCO.2003.07.125. J Clin Oncol. 2003. PMID: 12560431 Clinical Trial.

9

Adjuvant therapy in gastric cancer: can we prevent recurrences?

Meyerhardt JA, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Oncology (Williston Park). 2003 May;17(5):714-21, 728; discussion 728-9, 732-3. Oncology (Williston Park). 2003. PMID: 12800796 Free article. Review.

10

Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Cancer. 2003 Aug 1;98(3):484-95. doi: 10.1002/cncr.11544. Cancer. 2003. PMID: 12879464 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters